Pure Global: Brazil's AI MedTech Gambit - Navigating ANVISA's New Fast-Track & Privacy Traps. episode artwork

EPISODE · Mar 24, 2026 · 1 MIN

Pure Global: Brazil's AI MedTech Gambit - Navigating ANVISA's New Fast-Track & Privacy Traps.

from LATAM MedTech Insights

This week, we dive into a major regulatory shift in Brazil. ANVISA has just launched an exciting fast-track approval process for AI-powered medical software, creating a huge opportunity for MedTech innovators to enter Latin America's biggest market faster than ever before. But this new speed comes with a hidden challenge. The new pathway is tied to incredibly strict data privacy and cybersecurity rules based on Brazil's LGPD. These new requirements around data storage and patient consent are already creating significant hurdles, turning a golden opportunity into a complex compliance trap for unprepared companies. We explore a real-world case of a US MedTech company whose Brazilian launch was stopped in its tracks by these new data privacy rules, forcing them into a difficult and expensive decision. Their cutting-edge diagnostic tool is ready, but their data is not. Key Takeaways This Episode: 1. What are the specific criteria for ANVISA's new AI software fast-track pathway? 2. How do Brazil's new data privacy mandates specifically impact MedTech device submissions? 3. Will your existing international clinical data be considered valid under the new patient consent rules? 4. What are the real costs and penalties for non-compliance with Brazil's data localization requirements? 5. Does the new regulation give local Brazilian MedTech companies an unfair advantage? 6. How can you redesign your regulatory strategy to seize the fast-track opportunity while avoiding the privacy trap? 7. What specific cybersecurity vulnerabilities is ANVISA now targeting in its assessments? Struggling to keep up with the dynamic regulatory landscape in Latin America? At Pure Global, we offer end-to-end regulatory consulting for MedTech and IVD companies. We combine local, on-the-ground expertise in markets like Brazil with advanced AI tools to streamline your global market access. Don’t let complex regulations be a barrier to entry. Contact us at [email protected] or visit us at https://pureglobal.com/ to learn how we can accelerate your path to market.

Episode metadata supplied by the publisher feed · Published Mar 24, 2026

Embed this episode

NOW PLAYING

Pure Global: Brazil's AI MedTech Gambit - Navigating ANVISA's New Fast-Track & Privacy Traps.

0:00 1:56

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of LATAM MedTech Insights?

This episode is 1 minute long.

When was this LATAM MedTech Insights episode published?

This episode was published on March 24, 2026.

Can I download this LATAM MedTech Insights episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!